{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:43:06Z","timestamp":1759588986869,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.clineuro.2010.02.008","type":"journal-article","created":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T04:36:41Z","timestamp":1268714201000},"page":"467-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification and comparison of adverse events for preparations of IVIG in patients with neuromuscular diseases"],"prefix":"10.1016","volume":"112","author":[{"given":"Janel O.","family":"Nadeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunee","family":"Bhibhatbhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"McDougall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cory","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2010.02.008_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/(SICI)1097-4598(199603)19:3<388::AID-MUS20>3.0.CO;2-N","article-title":"Complications of intravenous gammaglobulin in neuromuscular and other diseases","volume":"19","author":"Bertorini","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clineuro.2010.02.008_bib2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"Bruton","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.clineuro.2010.02.008_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/WCO.0b013e3282ff5b8f","article-title":"Use of intravenous immunoglobulin and plasma exchange in neurological disease","volume":"21","author":"Linker","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.clineuro.2010.02.008_bib4","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"1","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2010.02.008_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ncpneuro0376","article-title":"Drug Insight: the use of intravenous immunoglobulin in neurology\u2014therapeutic considerations and practical issues","volume":"3","author":"Gold","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.clineuro.2010.02.008_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","article-title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clineuro.2010.02.008_bib7","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1001\/jama.1990.03450240091046","article-title":"NIH consensus conference. Intravenous immunoglobulin. Prevention and treatment of disease","volume":"264","author":"Anonymous","year":"1990","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.clineuro.2010.02.008_bib8","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s100720200011","article-title":"High-dose intravenous immunoglobulin G treatment of myasthenia gravis","volume":"23","author":"Ferrero","year":"2002","journal-title":"Neurol Sci"},{"key":"10.1016\/j.clineuro.2010.02.008_bib9","first-page":"11","article-title":"Intravenous immune globulin use in Canada","volume":"10","author":"Hanna","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.clineuro.2010.02.008_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.biologicals.2008.02.003","article-title":"Comparative pharmacokinetics of liquid and lyophilized formulations of IV RhIG immune globulin","volume":"36","author":"Sinclair","year":"2008","journal-title":"Biologicals"},{"issue":"Suppl. 1","key":"10.1016\/j.clineuro.2010.02.008_bib11","first-page":"79","article-title":"Side-effects of intravenous immune globulins","volume":"97","author":"Duhem","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clineuro.2010.02.008_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-121-4-199408150-00004","article-title":"Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors","volume":"121","author":"Sekul","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clineuro.2010.02.008_bib13","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00415-003-1085-1","article-title":"Side effects of intravenous immunoglobulins in neurological autoimmune disorders\u2014a prospective study","volume":"250","author":"Stangel","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.clineuro.2010.02.008_bib14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/01.wnl.0000256698.69121.45","article-title":"IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial","volume":"68","author":"Zinman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.02.008_bib15","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s10067-007-0694-y","article-title":"Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases","volume":"26","author":"Tufan","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clineuro.2010.02.008_bib16","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1212\/WNL.59.12_suppl_6.S13","article-title":"Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies","volume":"59","author":"Dalakas","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.02.008_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/157489008784705359","article-title":"Effect of immunoglobulin therapy on blood viscosity and potential concerns of thromboembolism, especially in patients with acute Kawasaki disease","volume":"3","author":"Baba","year":"2008","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"10.1016\/j.clineuro.2010.02.008_bib18","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/01.WNL.0000068335.01620.9D","article-title":"The clinical features of 16 cases of stroke associated with administration of IVIg","volume":"60","author":"Caress","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.02.008_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-199921030-00003","article-title":"Adverse effects of intravenous immunoglobulin therapy","volume":"21","author":"Nydegger","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.clineuro.2010.02.008_bib20","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/WNL.57.9.1699","article-title":"Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders","volume":"57","author":"Grillo","year":"2001","journal-title":"Neurology"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846710000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846710000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:27:56Z","timestamp":1759588076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846710000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0303846710000521"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2010.02.008","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and comparison of adverse events for preparations of IVIG in patients with neuromuscular diseases","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2010.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}